A company that’s developed a magnetic feeding tube for critically ill patients has raised $250,000. Syncro Medical Innovations‘ fundraising was revealed in a regulatory document filed with the U.S. Securities and Exchange Commission. The funding came in the form of debt from one investor. Syncro CEO Gary Wakeford didn’t return a call. The company sells […]
Columbus-based skin biopsy device maker CleveX Inc. is seeking a $637,500 loan that it would use to purchase equipment and machinery to boost production capacity for its ExiClip line of devices. Youngstown-based Syncro Medical Innovations is looking for a $490,500 loan to protect intellectual property and acquire equipment and machinery.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Syncro Medical Innovations has raised $500,000 in debt to continue development of a feeding tube for critically ill patients, according to a filing with the Securities and Exchange Commission. The latest funding follows an $800,000 infusion of capital in May and another $500,000 last summer. Both of those also came in the form of debt. […]
Syncro Medical Innovations has raised additional debt to help pay for aggressively pushing an improved version of its innovative feeding tube to market. The Youngstown startup has been selling the Syncro BlueTube feeding tube to at least one hospital for four years. But after investing $2 million over the last two years to significantly change […]
The money will help help bring its Syncro Blue Tube device to market by the end of this year.
Altogether, there are easily $50 million in health-related federal earmarks from Ohio legislators that could fund projects from the James Cancer Hospital at Ohio State University to a Youngstown company whose device is ideal for victims of battlefield trauma. Votes in Senate and House committees are expected this month to determine whether the institutions would get some, all or any of their requests.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.